ABSTRACT
Background Protecting healthcare workers (HCW) from Coronavirus Disease-19 (COVID-19) is critical to preserve the functioning of healthcare systems. We therefore assessed seroprevalence and identified risk factors for Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) seropositivity in this population.
Methods Between June 22nd and August 15th 2020, employees from healthcare institutions in Northern/Eastern Switzerland were screened for SARS-CoV-2 antibodies. We recorded baseline characteristics, non-occupational and occupational risk factors. We used pairwise tests of associations and multivariable logistic regression to identify factors associated with seropositivity.
Findings Among the 4’664 included HCW from 23 healthcare facilities, 139 (3%) were seropositive. Non-occupational exposures independently associated with seropositivity were contact with a COVID-19 positive household (adjusted OR=54, 95%-CI: 31-97) and stay in a COVID-19 hotspot (aOR=2·2, 95%-CI: 1·1-3·9). Blood group 0 vs. non-0 (aOR=0·4, 95%-CI: 0·3-0·7), active smoking (aOR=0·5, 95%-CI: 0·3-0·9) and living with children <12 years (aOR=0·3, 95%-CI: 0·2-0·6) were associated with decreased risk. Occupational risk factors were close contact to COVID-19 patients (aOR=2·8, 95%-CI: 1·5-5·5), exposure to COVID-19 positive co-workers (aOR=2·0, 95%-CI: 1·2-3·1), poor knowledge of standard hygiene precautions (aOR=2·0, 95%-CI: 1·3-3·2), and frequent visits to the hospital canteen (aOR=1·9, 95%-CI: 1·2-3·1).
Interpretation We identified several modifiable factors associated with SARS-CoV-2 seropositivity among our HCW. Living with COVID-19 positive households showed by far the strongest association. The lower risk among those living with children, even after correction for multiple confounders, is remarkable and merits further study.
Funding Swiss National Sciences Foundation, Federal Office of Public Health, Health Department Canton of St. Gallen
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
- Swiss National Sciences Foundation (Project Grant No 31CA30_196544; Ambizione Grant No PZ00P3_179919 to PK) - Federal Office of Public Health - Health Department Canton of St. Gallen
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the ethics committee of Eastern Switzerland (#2020-00502)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The authors may provide the original data upon reasonal request.
